Related Experiment Video
Updated: Oct 8, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
A critical approach to noncardiac chest pain: pathophysiology, diagnosis, and treatment
1Department of Gastroenterology and Hepatology, University of Utah Health Sciences Center, Salt Lake City 84105, USA.
Insights
Unexplained chest pain (UCP) affects many patients with normal coronary angiograms. Gastroesophageal reflux disease is a common cause, best diagnosed with 24-h pH monitoring and treated with acid suppression.
Area of Science:
- Gastroenterology
- Cardiology
- Internal Medicine
Background:
- Coronary angiography reveals non-significant coronary artery disease in approximately 30% of patients presenting with chest pain.
- These patients are diagnosed with noncardiac or unexplained chest pain (UCP), experiencing significant morbidity and healthcare costs despite a generally good prognosis.
- The pathophysiology of UCP is complex, involving potential cardiac, esophageal, and psychiatric factors, with visceral hyperalgesia playing a key role.
Purpose of the Study:
- To investigate the role of esophageal disorders in unexplained chest pain (UCP).
- To evaluate diagnostic and management strategies for UCP patients.
- To differentiate between cardiac and esophageal etiologies of UCP.
Main Methods:
- Review of clinical symptoms and diagnostic tests for UCP.
- Focus on the prevalence of gastroesophageal reflux disease (GERD) versus esophageal motility disorders in UCP patients.
- Evaluation of 24-h pH monitoring as a diagnostic tool.
- Assessment of empiric high-dose acid suppression therapy.
Main Results:
- Clinical symptoms are often unreliable for distinguishing cardiac from esophageal causes of UCP.
- Gastroesophageal reflux disease is identified as the most common esophageal disorder associated with UCP, more so than esophageal motility disorders.
- Twenty-four-hour pH monitoring is deemed the most useful diagnostic test for UCP evaluation.
Conclusions:
- Gastroesophageal reflux disease is a primary contributor to unexplained chest pain (UCP) in patients with normal coronary angiograms.
- High-dose acid suppression therapy represents the most cost-effective initial management strategy for UCP.
- A structured clinical algorithm is proposed for the effective evaluation and treatment of unexplained chest pain.
Abstract:
Approximately 30% of coronary angiograms performed in this country are negative for significant coronary artery disease. These patients are classified as having noncardiac or unexplained chest pain (UCP). Despite the good overall prognosis, this condition has significant morbidity and costs. The pathophysiology of this condition is likely caused by overlapping cardiac, esophageal, and psychiatric abnormalities with visceral hyperalgesia playing a central role. Gastroenterologists are often consulted in the evaluation of these patients because esophageal disorders are among the most common conditions associated with UCP. However, clinical symptoms are unreliable in differentiating between esophageal and cardiac causes of UCP. Gastroesophageal reflux disease, not esophageal motility disorders, is the most common esophageal disorder present in patients with UCP. The most useful diagnostic test in the evaluation of UCP is 24-h pH monitoring. An initial empiric trial of high-dose acid suppression is the most cost-effective intervention in the management of these patients. A clinical algorithm is suggested for the evaluation and treatment of UCP.
Related Concept Videos
Angina III: Clinical Manifestations and Assessment
Angina V: Nursing Management
Pericarditis IV: Nursing Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina IV: Management
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
